Shuang Xu

Shuang Xu

Auto-generated profile, based on publicly available information

Shuang Xu

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen , Groningen

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in International Journal of Cardiology
Verified
Journal Article
Closed access
HNHuaner Ni
Huaner Ni
WLWeifeng Li
Weifeng Li
YZYing Zhuge
Ying Zhuge
SXShuang Xu
Shuang Xu
YWYue Wang
Yue Wang
FWFang Wang
Fang Wang

1 January 2021 in Atherosclerosis
Verified
Journal Article
Closed access
SXShuang Xu
Shuang Xu
HCHangwei Chen
Hangwei Chen
HNHuaner Ni
Huaner Ni
QDQiuyan Dai
Qiuyan Dai

18 June 2024 in Arthritis Care & Research
Verified
Journal Article
Open access
SXShuang Xu
Shuang Xu
WJWilliam Febry Jiemy
William Febry Jiemy
ABAnnemieke M. H. Boots
Annemieke M. H. Boots
SASuzanne Arends
Suzanne Arends
YSYannick Van Sleen
Yannick Van Sleen
MSMaria Sandovici
Maria Sandovici
Objective: Giant cell arteritis (GCA) is characterized by granulomatous inflammation of the medium‐ and large‐sized arteries accompanied by remodeling of the vessel wall. Fibroblast activation protein alpha (FAP) is a serine protease that promotes both inflammation and fibrosis. Here, we investigated the plasma levels and vascular expression of FAP in GCA.Methods: Plasma FAP levels were measured with enzyme‐linked immunosorbent assay in treatment‐naive patients with GCA (n = 60) and polymyalgia rheumatica (PMR) (n = 63) compared with age‐ and sex‐matched healthy controls (HCs) (n = 42) and during follow‐up, including treatment‐free remission (TFR). Inflamed temporal artery biopsies (TABs) of patients with GCA (n = 9), noninflamed TABs (n = 14), and aorta samples from GCA‐related (n = 9) and atherosclerosis‐related aneurysm (n = 11) were stained for FAP using immunohistochemistry. Immunofluorescence staining was performed for fibroblasts (CD90), macrophages (CD68/CD206/folate receptor beta), vascular smooth muscle cells (desmin), myofibroblasts (α‐smooth muscle actin), interleukin‐6 (IL‐6), and matrix metalloproteinase‐9 (MMP‐9).Results: Baseline plasma FAP levels were significantly lower in patients with GCA compared with patients with PMR and HCs and inversely correlated with systemic markers of inflammation and angiogenesis. FAP levels decreased even further at 3 months on remission in patients with GCA and gradually increased to the level of HCs in TFR. FAP expression was increased in inflamed TABs and aorta of patients with GCA compared with control tissues. FAP was abundantly expressed in fibroblasts and macrophages. Some of the FAP+ fibroblasts expressed IL‐6 and MMP‐9.Conclusion: FAP expression in GCA is clearly modulated both in plasma and in vessels. FAP may be involved in the inflammatory and remodeling processes in GCA and have utility as a target for imaging and therapeutic intervention.

14 March 2025 in Rheumatology
Verified
Journal Article
Open access
SXShuang Xu
Shuang Xu
WJWilliam F Jiemy
William F Jiemy
YSYannick Van Sleen
Yannick Van Sleen
JWJohanna Westra
Johanna Westra
JGJacoba C Graver
Jacoba C Graver
MSMaria Sandovici
Maria Sandovici
Objective: Giant cell arteritis (GCA) is a systemic vasculitis of large- and medium-sized arteries characterized by granulomatous inflammation and vascular remodelling. Although fibroblasts are the predominant cell type in the adventitia, their role in GCA pathogenesis is largely unknown. This study aimed to investigate the distribution of fibroblast subtypes in relation to vascular remodelling in GCA. Methods: Temporal artery biopsies (TAB) from patients with GCA (n = 9) and controls (n = 15) and aorta tissues from GCA (n = 9)- and atherosclerosis (n = 11)-related aneurysms were examined. Immunohistochemical and immunofluorescence staining for fibroblast subtype markers (CD90, platelet-derived growth factor receptor α [PDGFRA], fibroblast activation protein [FAP], podoplanin [PDPN], CD248, α-smooth muscle actin [α-SMA]), cellular proliferation (Ki67) and remodelling-related growth factors (TGF-β, fibroblast growth factor 21 [FGF21], platelet-derived growth factor B [PDGFB]) were performed to evaluate the distribution of fibroblast subtypes in relation to active remodelling pathways. To evaluate the role of FAP in TGF-β-induced fibroblast proliferation, human aortic adventitial fibroblasts (HAoAF) were stimulated in vitro with TGF-β and transfected with small interfering RNA targeting FAP. Results: In GCA-TAB, CD90+FAP+ activated fibroblasts and CD90+PDPN+ immunofibroblasts were predominantly located in the adventitia. CD90+α-SMA+ myofibroblasts were observed mainly in the intima, and CD90+CD248+ fibroblasts in the adventitia–media border and intima. High FGF21 and PDGFB expression in the intima was associated with intimal hyperplasia in GCA-positive TAB. GCA-affected aortas showed a different landscape of fibroblast subtypes: CD90+FAP+ activated fibroblasts, CD90+PDPN+ immunofibroblasts and CD90+CD248+ fibroblasts accumulated especially in structurally disrupted media. Approximately 80% of proliferative fibroblasts in TAB and aorta were FAP positive. FAP knockdown suppressed TGFβ-induced proliferation of HAoAF in vitro. Conclusion: This study documents a distinct spatial distribution pattern of fibroblast subtypes in GCA-affected arteries. The data suggest different roles for fibroblasts in remodelling of specific arterial vascular beds in GCA.

7 August 2025 in Rheumatology
Verified
Journal Article
Open access
SXShuang Xu
Shuang Xu
WJWilliam F Jiemy
William F Jiemy
AZAnqi Zhang
Anqi Zhang
FWFokke Walinga
Fokke Walinga
MNMiranda Nijenhuis
Miranda Nijenhuis
MSMaria Sandovici
Maria Sandovici
Objectives: Giant cell arteritis (GCA) is a large vessel vasculitis characterized by arterial wall inflammation and remodelling. Macrophages and fibroblasts are abundantly present in arteries affected by GCA, but their crosstalk in GCA pathogenesis is largely unknown. Here we investigated the interaction between macrophages and fibroblasts in GCA-affected arteries and in vitro. Methods: Immunostaining was performed to detect macrophages (CD68, CD206, FRβ), fibroblasts (CD90, CD200), GM-CSF, M-CSF, IL-6, MMP-3 and tenascin-C in GCA-positive temporal arteries (n = 9) and aorta tissues (n = 9). Serum tenascin-C levels were measured by ELISA in GCA patients (n = 36) and healthy controls (n = 46). In vitro, monocytes isolated from peripheral blood mononuclear cells of healthy donors (n = 10) were incubated with GM-CSF or M-CSF for 8 days to induce macrophage differentiation. GM-CSF/M-CSF-macrophage-conditioned medium (MCM) was added to human aortic adventitial fibroblast (HAoAF) cultures for 24 h. mRNA expression of proinflammatory cytokines(IL-6, IL-1β), growth factors (GM-CSF, M-CSF), matrix metalloproteinase (MMP-1, MMP-3), chemokines (CCL2, CX3CL1), extracellular matrix proteins (Col1a1, Col1a2, Col3a1, fibronectin-1, tenascin-C) and phenotypic markers (fibroblast activation protein [FAP], podoplanin [PDPN], α-smooth muscle actin, CD200) in cultured fibroblasts were examined by qPCR. Results: In GCA-affected arteries, pro-inflammatory CD90+IL-6+ fibroblasts, but not pro-resolving CD90+CD200+ fibroblasts, were spatially associated with macrophages. Adventitial CD90+ fibroblasts expressed GM-CSF and/or M-CSF, which linked to macrophage subset distribution. In vitro, both GM-CSF- and, to a lesser extent, M-CSF-derived MCM upregulated mRNA expression of IL-6, GM-CSF, M-CSF, CCL2, PDPN and CD200 in fibroblasts. Upregulation of IL-1β, MMP-3, Col3a1 and tenascin-C and downregulation of FAP in fibroblasts was observed with GM-CSF-derived MCM. Adventitial CD90+ fibroblasts in GCA-affected temporal arteries also expressed MMP-3 and tenascin-C. Serum levels of tenascin-C in patients with treatment-naïve GCA were significantly higher than those in healthy controls, showing a good diagnostic accuracy (area under the curve 0.89). Conclusion: The interaction between fibroblasts and macrophages may contribute to the chronicity and progression of GCA and deserves further investigation. Serum tenascin-C is a candidate biomarker for GCA diagnosis.

27 November 2025 in Rheumatology
Verified
Journal Article
Closed access
AZAnqi Zhang
Anqi Zhang
WJWilliam F Jiemy
William F Jiemy
YSYannick Van Sleen
Yannick Van Sleen
SXShuang Xu
Shuang Xu
MSMaria Sandovici
Maria Sandovici
KGKornelis S M van der Geest
Kornelis S M van der Geest
Objective: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are closely related chronic inflammatory diseases in which macrophages play a central role in the pathogenesis. This study compared macrophage-related immune profiles in subacromial bursal tissues affected by PMR and temporal arteries affected by GCA to identify shared therapeutic targets. Methods: Subacromial bursa biopsies (SABBs) were obtained from patients with active PMR (n = 11). Temporal artery biopsies (TABs) were collected from 14 patients with GCA. Immunohistochemical staining was performed for macrophage markers [CD68, CD64, CD86, CD206 and folate receptor (FR) β] and macrophage-related cytokines (GM-CSF, IL-6, IL-23, IFN-γ, M-CSF and TNF-α). The percentage of positively stained cells was quantitatively scored. Results: All macrophage-related markers and cytokines were expressed in both PMR-affected SABBs and GCA-affected TABs. The proportions of cells expressing macrophage markers (CD68, CD64, CD86 and CD206) and macrophage-related cytokines (GM-CSF, IL-6, IL-23, IFN-γ, M-CSF and TNF-α) were comparable between the two tissue types. However, the expression of FRβ was relatively higher in GCA TABs than in PMR SABBs. Conclusion: The macrophage immune profiles are remarkably similar in PMR SABBs and GCA TABs. This study underscores the concept of PMR and GCA as a disease spectrum and identifies shared therapeutic targets for both PMR and GCA.